2011
DOI: 10.1016/j.jinorgbio.2011.05.015
|View full text |Cite
|
Sign up to set email alerts
|

Dinuclear copper complexes of organic claw: Potent inhibition of protein tyrosine phosphatases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 22 publications
(9 citation statements)
references
References 47 publications
0
9
0
Order By: Relevance
“…It is different from dinuclear copper complexes of organic claw ligands which exhibit potent and almost the same inhibition against PTP1B and SHP-1 with IC 50 values ranging from 0.15 to 0.31 lM, about Fig. 1 The structure of complexes 1-5 twofold weaker inhibition against PTP-MEG2, tenfold weaker inhibition against TCPTP (Ma et al 2011a), and copper complexes of Schiff base ligands containing 3,5-substituted-4-salicylideneamino-3,5-dimethyl-1,2,4-triazole which strongly inhibit PTP1B with IC 50 from 0.038 to 0.091 lM, three-to fourfold selectivity against PTP1B over TCPTP and PTP-MEG2, and three-to ninefold over SHP-1 (Ma et al 2011b). It is interesting that these three types of copper complexes do not inhibit SHP-2.…”
Section: Ptp Inhibition Studiesmentioning
confidence: 88%
“…It is different from dinuclear copper complexes of organic claw ligands which exhibit potent and almost the same inhibition against PTP1B and SHP-1 with IC 50 values ranging from 0.15 to 0.31 lM, about Fig. 1 The structure of complexes 1-5 twofold weaker inhibition against PTP-MEG2, tenfold weaker inhibition against TCPTP (Ma et al 2011a), and copper complexes of Schiff base ligands containing 3,5-substituted-4-salicylideneamino-3,5-dimethyl-1,2,4-triazole which strongly inhibit PTP1B with IC 50 from 0.038 to 0.091 lM, three-to fourfold selectivity against PTP1B over TCPTP and PTP-MEG2, and three-to ninefold over SHP-1 (Ma et al 2011b). It is interesting that these three types of copper complexes do not inhibit SHP-2.…”
Section: Ptp Inhibition Studiesmentioning
confidence: 88%
“…Binuclear copper complexes with phosphono-containing multidentate ligands 23-25 display similar inhibition against PTP1B and TCPTP, with IC 50 values ranging from 0.15 to 0.24 lM, *10-, 30-, and more than 100-fold stronger inhibition than their inhibition of SHP-1, SHP-2, and PTP-MEG2 (111). The dinuclear copper complexes with organic claw ligands 26-28 exhibit almost the same inhibition of PTP1B and SHP-1, with IC 50 values in a range of 0.15-0.31 lM, *2-fold stronger inhibition than their inhibition of PTP-MEG2 and 10-fold stronger than their inhibition of TCPTP (66). Although the copper complexes with multibenzimidazoles 29-33 have almost the same inhibitory effects on PTP1B, TCPTP, and PTP-MEG2, with IC 50 values from 0.12 to 0.25 lM, they display about a 10-fold weaker inhibition of SHP-1 (61).…”
Section: Copper Complexesmentioning
confidence: 95%
“…1 H NMR (400 MHz, DMSO-d6): δ 6.81 (s, 0H), 6.59 (s, 0H), 3.75 (s, 1H), 3.38 (s, 1H), 2.10 (s, 1H), 2.07 (s, 1H). 13 The catalyst BBTA was synthesized by modification of previous published procedures [44,45] as follows: NaOH (10 g) was added to 140 mL aqueous solution containing iminodiacetic acid (0.125 mol) and p-cresol (0.063 mol) under ice water bath. Then paraformaldehyde (0.063 mol) was added slowly into the mixture and the solution was stirred for 30 min at room temperature.…”
Section: Synthesismentioning
confidence: 99%